Arkolith/Insider Trading/BIOR/Form 4

Athyrium Opportunities 2020 LP

10% OwnerBIORA THERAPEUTICS, INC. (BIOR) · full profile →Form 4 · filed Nov 14, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 9, 2022Buy(P)12.5M——42.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 9, 2022Disposed to issuer(D)8.1M——0
Nov 9, 2022Grant(A)8.1M——8.1M
Nov 9, 2022Buy(P)12.5M——12.5M

Transaction Codes

P
Open-market purchase
D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-035696) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML